Skip to main content
Caplight Logo









Nurocor

Nurocor

Private
Austin, TexasHealthcare & Life Scienceshttps://nurocor.com/

Last Round

Strategic

Jul 14, 2025

Total Funding Raised

$1M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nurocor is a life sciences technology company that provides a platform for digitalized clinical development to help organizations accelerate clinical trial lifecycles.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Data Governance, Workflow Automation, Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial automationmetadata managementclinical developmentmetadata repositoryMDRclinical trial softwareregulatory complianceeClinicalprotocol automationclinical data standardsCDISCvertical SaaSclinical workflowgenerative AIpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurocor Comparables

Compare Nurocor with similar companies based on industry and business-model similarity.

Nurocor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Faro Health
87%
Certara
81%
eClinical Solutions
78%

Nurocor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 14, 2025
VC RoundOct 16, 2024

Key People

Founding team and executive leadership

Alex Lazar

Chief Executive Officer, Founder, Board Member, President, and CEO

Founding Team

Nurocor Investors

Notable investors and investment history

Nurocor investors
InvestorRounds
Frontier Venture CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 38% MoM.

  • Jul 20, 2026

    Open roles increased to 28, 3.5x the trailing average.

Nurocor Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nurocor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nurocor's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range50
Year Founded2017
Last FundingJul 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?